Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose fasting bioequivalence of desmopressin ODT 240 mcg vs MINIRINMELT OD 240 mcg in healthy Japanese adults
jRCT2051250108Recruiting
- Sponsor
- Viatris
- Start
- Sep 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised trial of desmopressin in arginine vasopressin deficiency (CDI) and nocturnal enuresis (NE) (2 arms), sponsored by Viatris. Started Sep 2025; status: recruiting.
02
Drugs
desmopressin
03
Conditions
arginine vasopressin deficiency (CDI)nocturnal enuresis (NE)
Beyond the preview
Go deeper on jRCT2051250108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051250108.